Xenetic Biosciences (XBIO) EBT Margin (2011 - 2026)
Xenetic Biosciences (XBIO) posted EBT Margin of -140.72% for Q2 2026, down 23.72 percentage points from -117.00% a year earlier and down 84.17 percentage points from the prior quarter.
Powered by 
Analysis
Xenetic Biosciences (XBIO) EBT Margin (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Xenetic Biosciences was -78.32%, up 52.17 percentage points year-over-year; for FY2025, it came in at -95.23%, up 72.92 percentage points from FY2024.
- Annual EBT Margin has increased for six consecutive years, with a five-year change of +3094.59 percentage points (FY2020 to FY2025).
- In prior years, Xenetic Biosciences' EBT Margin was -168.16% in FY2024 (+9.63 pp), -177.79% in FY2023 (+215.78 pp), -393.57% in FY2022 (+101.55 pp) and -495.12% in FY2021 (+2694.70 pp).
- The Q2 2026 figure stands as the lowest quarterly EBT Margin since Q1 2025.
- On a year-over-year basis, EBT Margin increased in seven of the last eight quarters, with an average year-over-year change of +59.41 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q3 2021, with a gain of 8651.89 percentage points; the weakest was Q2 2022, with a drop of 252.75 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was -56.56% (Q1 2026), -81.30% (Q4 2025) and -53.04% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Xenetic Biosciences | 5.46 Mn | -20.36 Mn | - | -140.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -140.72% |
| Mar 31, 2026 | -56.56% |
| Dec 31, 2025 | -81.30% |
| Sep 30, 2025 | -53.04% |
| Jun 30, 2025 | -117.00% |
| Mar 31, 2025 | -152.25% |
| Dec 31, 2024 | -169.41% |
| Sep 30, 2024 | -81.32% |
| Jun 30, 2024 | -184.11% |
| Mar 31, 2024 | -248.31% |
| Dec 31, 2023 | -186.87% |
| Sep 30, 2023 | -187.62% |
| Jun 30, 2023 | -184.05% |
| Mar 31, 2023 | -151.06% |
| Dec 31, 2022 | -321.03% |
| Sep 30, 2022 | -204.66% |
| Jun 30, 2022 | -644.83% |
| Mar 31, 2022 | -416.39% |
| Dec 31, 2021 | -563.44% |
| Sep 30, 2021 | -386.77% |
API Access
Xenetic Biosciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=XBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "XBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=XBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();